Including Patient-Reported Outcomes and Patient-Reported Resource-Use Questionnaires in Studies

Academic Radiology - Tập 21 - Trang 1129-1137 - 2014
Brian W. Bresnahan1,2, Sean D. Rundell1,2
1Department of Radiology, University of Washington, 1959 NE Pacific Street, Seattle, WA 98195
2Comparative Effectiveness, Cost and Outcomes Research Center, University of Washington, Seattle, Washington

Tài liệu tham khảo

http://www.pcori.org (accessed March 17, 2014). Institute of Medicine, http://www.nap.edu/openbook.php?record_id=12648 (accessed March 21, 2014). Inglehart, 2009, Prioritizing comparative-effectiveness research—IOM recommendations, NEJM, 361, 325, 10.1056/NEJMp0904133 Pandharipande, 2009, Comparative effectiveness research: what it means for radiology, Radiology, 253, 600, 10.1148/radiol.2533091286 http://www.ahrq.gov/(accessed March 17, 2014). Chassany, 2002, Patient-reported outcomes: the example of health-related quality of life—a European guidance document for the improved integration of health-related quality of life assessment in the drug regulation process, DIJ, 36, 209 http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003637.pdf (accesses March 12, 2014). United States Health and Human Services, Food and Drug Administration, guidance for industry, patient-reported outcome measures: use in medical product development to support labeling claims, December 2009. (http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/default.htm, accessed March 12, 2014). 1998 McDowell, 1996 http://www.fda.gov/Drugs/DevelopmentApprovalProcess/DrugDevelopmentToolsQualificationProgram/ucm284077.htm (accessed March 18, 2014). http://phi.uhce.ox.ac.uk/home.php, (accessed March 17, 2014). Revicki, 2007, Documenting the rationale and psychometric characteristics of patient reported outcomes for labeling and promotional claims: the PRO Evidence Dossier, Qual Life Res, 16, 717, 10.1007/s11136-006-9153-5 Patrick, 2011, Content validity—Establishing and reporting the evidence in newly-developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: Part 1-Eliciting concepts for a new PRO instrument, Value Health, 14, 967, 10.1016/j.jval.2011.06.014 Patrick, 2011, Content validity—Establishing and reporting the evidence in newly-developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: Part 2 – assessing respondent understanding, Value Health, 14, 978, 10.1016/j.jval.2011.06.013 http://www.nihpromis.org/about/overview (accessed March 13, 2014). http://www.assessmentcenter.net/documents/InstrumentLibrary.pdf, accessed March 21, 2014). Gold MR, Siegel JE, Russell LB, et al. Cost-effectiveness in health and medicine. 1996. Ramsey, 2005, Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report, Value in Health, 8, 521, 10.1111/j.1524-4733.2005.00045.x Neumann, 2004 Drummond, 2005 Wilson, 1995, Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes, JAMA, 273, 59, 10.1001/jama.1995.03520250075037 http://www.who.int/classifications/icf/en/; accessed on March 14, 2014. Calvert, 2013, The CONSORT patient-reported outcome (PRO) extension: implications for clinical trials and practice, Health and Quality of Life Outcomes, 11, 184, 10.1186/1477-7525-11-184 Gondek, 2007, Current status of patient-reported outcomes in industry-sponsored oncology clinical trials and product labels, J Clin Oncol, 25, 5087, 10.1200/JCO.2007.11.3845 Garrison, 2011, Using cost-effectiveness analysis to support R&D portfolio prioritization for product innovations in measles vaccination, J Infectious Diseases, 204, S124, 10.1093/infdis/jir114 Hollingworth, 2007, Technology assessment in radiology: putting the evidence in evidence-based radiology, Radiology, 244, 31, 10.1148/radiol.2441051790 Smeets, 2011, Arthritis Care & Research, 63, S158, 10.1002/acr.20542 Roland, 1983, A study of the natural history of back pain. Part I: development of a reliable and sensitive measure of disability in low-back pain, Spine (Phila Pa 1976), 8, 141, 10.1097/00007632-198303000-00004 Roland, 2000, The Roland-Morris Disability Questionnaire and the Oswestry Disability Questionnaire, Spine (Phila Pa 1976), 25, 3115, 10.1097/00007632-200012150-00006 Fairbank, 1980, The Oswestry Low Back Pain Disability Questionnaire, Physiotherapy, 66, 271 Graves, 2012, Early imaging for acute low back pain one-year health and disability outcomes among Washington State workers, Spine, 37, 1617, 10.1097/BRS.0b013e318251887b Friedly, 2012, Study protocol–Lumbar Epidural Steroid Injections for Spinal Stenosis (LESS): a double-blind randomized controlled trial of epidural steroid injections for lumbar spinal stenosis among older adults, BioMed Central Musculoskeletal Disorders, 13, 48, 10.1186/1471-2474-13-48 Sloan, 2007, Integrating patient-reported outcomes into cancer symptom management clinical trials supported by the National Cancer Institute–sponsored clinical trials networks, J Clin Oncol, 25, 5070, 10.1200/JCO.2007.12.7670 Brunner, 2007, Issues and challenges with integrating patient-reported outcomes in clinical trials supported by the National Cancer Institute–sponsored clinical trials networks, J Clin Oncol, 25, 5051, 10.1200/JCO.2007.11.3324 Minasian, 2007, Health-related quality of life and symptom management research sponsored by the National Cancer Institute, J Clin Oncol, 25, 5128, 10.1200/JCO.2007.12.6672 Osoba, 2011, Health-related quality of life and cancer clinical trials, Therapeutic Advances in Medical Oncology, 3, 57, 10.1177/1758834010395342 Billingham, 1999, Methods for the analysis of quality-of-life and survival data in health technology assessment, Health Technol Assess, 3, 10.3310/hta3100 Center for Medical Technology Policy, Recommendations for incorporating patient-reported outcomes (PROs) into clinical comparative effectiveness research (CER) in adult oncology, effectiveness guidance document, Published Version 1.0, May 20, 2012. (http://www.cmtpnet.org/resource-center/view/egd-on-patient-reported-outcomes-in-cer-and-adult-oncology/; accessed March 17, 2014). Yanez, 2013, The FACT-G7: a rapid version of the functional assessment of cancer therapy-general (FACT-G) for monitoring symptoms and concerns in oncology practice and research, Annals of Oncology, 24, 1073, 10.1093/annonc/mds539 http://www.facit.org/FACITOrg/Questionnaires (accessed March 21, 2014). Carlos, 2012, Patient centered outcomes in imaging: quantifying value, JACR, 9, 725